595569-62-3Relevant academic research and scientific papers
SERINE/THREONINE KINASE INHIBITORS
-
Paragraph 00264, (2015/07/16)
Compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such diseases, or associated pathological conditions are disclosed.
A novel estrogen receptor ligand template
Sibley, Robert,Hatoum-Mokdad, Holia,Schoenleber, Robert,Musza, Laszlo,Stirtan, William,Marrero, Diana,Carley, William,Xiao, Hong,Dumas, Jacques
, p. 1919 - 1922 (2007/10/03)
Three synthetic routes towards a novel estrogen receptor ligand template based on a rigid bicyclo-[3.3.1]-nonene core have been investigated. The prototype compound exhibits potent binding at the ERβ receptor and promising estrogen receptor subtype select
